Skip to main content

Advertisement

SpringerLink
Log in

Management of Bilateral Metachronous Adrenal Metastases from Hepatocellular Carcinoma

  • Case Report
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

    Article  PubMed  Google Scholar 

  2. Machairas N, Tsilimigras DI, Pawlik TM. State-of-the-art surgery for hepatocellular carcinoma. Langenbecks Arch Surg. 2021;406(7):2151–62.

    Article  PubMed  Google Scholar 

  3. Machairas N, Tsilimigras DI, Pawlik TM. Current landscape of immune checkpoint inhibitor therapy for hepatocellular carcinoma. Cancers (Basel). 2022;14(8).

  4. Tsilimigras DI, et al. Serum alpha-fetoprotein levels at time of recurrence predict post-recurrence outcomes following resection of hepatocellular carcinoma. Ann Surg Oncol. 2021;28(12):7673–83.

    Article  PubMed  Google Scholar 

  5. Schlageter M, et al. Clinicopathological features and metastatic pattern of hepatocellular carcinoma: an autopsy study of 398 patients. Pathobiology. 2016;83(6):301–7.

    Article  PubMed  Google Scholar 

  6. Uka K, et al. Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma. World J Gastroenterol. 2007;13(3):414–20.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Llovet JM, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359(4):378–90.

    Article  CAS  PubMed  Google Scholar 

  8. Park JS, et al. What is the best treatment modality for adrenal metastasis from hepatocellular carcinoma? J Surg Oncol. 2007;96(1):32–6.

    Article  PubMed  Google Scholar 

  9. Staubitz JI, et al. Survival after adrenalectomy for metastatic hepatocellular carcinoma: a 25-year institutional experience. World J Surg. 2021;45(4):1118–25.

    Article  CAS  PubMed  Google Scholar 

  10. Alexandrescu ST, et al. Aggressive surgical approach in patients with adrenal-only metastases from hepatocellular carcinoma enables higher survival rates than standard systemic therapy. Hepatobiliary Pancreat Dis Int. 2021;20(1):28–33.

    Article  CAS  PubMed  Google Scholar 

  11. Okabe K, et al. Case report–a patient who has survived more than 4 years with repeated resection for bilateral adrenal metastasis from hepatocellular carcinoma. Gan To Kagaku Ryoho. 2002;29(12):2142–5.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 2nd Department of Propaedeutic Surgery, National and Kapodistrian University of Athens, Ag. Thoma 17, 11527, Athens, Greece

    Panagiotis Dorovinis, Nikolaos Machairas, Myrto D. Keramida, Stylianos Kykalos, Dimitrios Dimitroulis & Georgios C. Sotiropoulos

Authors
  1. Panagiotis Dorovinis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nikolaos Machairas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Myrto D. Keramida
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Stylianos Kykalos
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dimitrios Dimitroulis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Georgios C. Sotiropoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conceptualization, P.D., N.M., and G.C.S.; methodology, P.D. and N.M.; investigation, P.D., S.K., and M.D.K.; resources, D.D.; writing—original draft preparation, P.D., M.D.K, and N.M.; writing—review and editing, N.M., S.K., and G.C.S.; visualization, N.M. and P.D.; supervision, G.C.S. and D.D.; project administration, G.C.S. All authors have read and agreed to the published version of the manuscript.

Corresponding author

Correspondence to Panagiotis Dorovinis.

Ethics declarations

Informed Consent

Not applicable.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dorovinis, P., Machairas, N., Keramida, M.D. et al. Management of Bilateral Metachronous Adrenal Metastases from Hepatocellular Carcinoma. J Gastrointest Canc 54, 979–981 (2023). https://doi.org/10.1007/s12029-022-00854-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-022-00854-8

Keywords

Search

Navigation